![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1351498
¼¼°èÀÇ ÇÚµåÇïµå ¼ö¼ú±â±¸ ½ÃÀå ±Ô¸ð : Á¦Ç°º°, ¿ëµµº°, ÃÖÁ¾ ¿ëµµº°, ¿¹Ãø(2023-2032³â)Hand-held Surgical Instruments Market Size - By Product (Forceps, Retractors, Graspers, Scalpels, Cannulas), By Application (Orthopedic Surgery, Cardiology, Ophthalmology, Wound Care, Urology & Gynecology Surgery), By End-use, & Forecast, 2023 - 2032 |
¼¼°è ÇÚµåÇïµå ¼ö¼ú±â±¸ ½ÃÀåÀº 2023³âºÎÅÍ 2032³â±îÁö ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR) 7.4%¸¦ ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
¼¼°èº¸°Ç±â±¸(WHO)ÀÇ Ã߻꿡 µû¸£¸é 2030³â±îÁö ¼¼°è Àα¸ 6¸í Áß 1¸íÀÌ 60¼¼ ÀÌ»óÀÌ µÉ °ÍÀ̶ó°í ÇÕ´Ï´Ù. ³ëÀεéÀº ´Ù¾çÇÑ °Ç° ¹®Á¦·Î ÀÎÇØ ÀÇ·áÀû °³ÀÔÀÌ ÇÊ¿äÇÑ °æ¿ì°¡ ¸¹±â ¶§¹®¿¡ ÀÌ·¯ÇÑ Àα¸ Áõ°¡´Â ÈÞ´ë¿ë ¼ö¼ú±â±¸¿Í °°Àº ÀÇ·á±â±â¿¡ ´ëÇÑ °·ÂÇÑ ¼ö¿ä¸¦ âÃâÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ½ÅÈï °æÁ¦ÀÇ ÀÇ·á ÀÎÇÁ¶ó È®Ãæ°ú ÀÇ·á ¿É¼Ç¿¡ ´ëÇÑ ÁֹεéÀÇ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ¿Ü°ú ¼ö¼ú¿¡ ´ëÇÑ Á¢±Ù¼ºÀÌ ³ô¾ÆÁ® ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖÀ¸¸ç, Äڷγª19 »çÅ·ΠÀÎÇØ ÀÇ·á ÁغñÀÇ Á߿伺ÀÌ ºÎ°¢µÇ¸é¼ ±ä±ÞÇÑ ÀÇ·á ¼ö¿ä¿¡ ´ëÀÀÇϱâ À§ÇØ ÀÇ·á ½Ã¼³¿¡ ÇÚµåÇïµå ±â±â¸¦ Æ÷ÇÔÇÑ ÃÖ÷´Ü ¼ö¼ú Àåºñ¿¡ ´ëÇÑ ÅõÀÚ¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù.
Àüü ÇÚµåÇïµå ¼ö¼ú±â±¸ ½ÃÀåÀº Á¦Ç°, ¿ëµµ, ÃÖÁ¾ ¿ëµµ, Áö¿ªº°·Î ¼¼ºÐȵ˴ϴÙ.
È®Àå±â Á¦Ç° ºÎ¹®Àº ÃÖ¼Ò Ä§½À ¼ö¼ú ±â¹ýÀÇ º¸±ÞÀÌ Áõ°¡ÇÔ¿¡ µû¶ó 2032³â±îÁö 7.7%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ·¯ÇÑ ±â±â´Â ´Ù¾çÇÑ ½Ã¼ú ½Ã Ç÷°ü°ú Á¶Á÷, Á¼Àº ÇØºÎÇÐÀû ±¸Á¶¹°À» È®ÀåÇÏ¿© Á¢±ÙÀ» ¿ëÀÌÇÏ°Ô Çϰí Á¶Á÷ ¿Ü»óÀ» ÁÙÀÌ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ȯÀÚµéÀÇ ¼±È£µµ°¡ º¸´Ù ÃÖ¼Ò Ä§½ÀÀûÀ̰í ȸº¹ ½Ã°£ÀÌ ÂªÀº Ä¡·á·Î À̵¿ÇÔ¿¡ µû¶ó Á¤È®Çϰí È¿À²ÀûÀÎ ÇÚµåÇïµå È®Àå±â¿¡ ´ëÇÑ ¼ö¿ä°¡ ±ÞÁõÇϰí ÀÖ½À´Ï´Ù.
¼ºÇü¿Ü°ú ÀÀ¿ë ºÐ¾ß´Â 2023-2032³â 8.3%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ´Â ¼¼°èÀûÀ¸·Î ¼ºÇü¼ö¼ú¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö°í Àֱ⠶§¹®ÀÔ´Ï´Ù. ¼ºÇü¿Ü°ú ÀÇ»çµéÀº ¾È¸é°Å»ó¼ú, À¯¹æÈ®´ë¼ú, ÄÚ ¼ºÇü¼ú µîÀÇ ¼ö¼ú ½Ã Á¤¹ÐÇÏ°í ¼¶¼¼ÇÑ Á¶Á÷ Á¶ÀÛÀ» À§ÇÑ Æ¯¼ö ±â±¸°¡ ÇÊ¿äÇÕ´Ï´Ù. ¶ÇÇÑ, Àç·á¿Í ÀÎü°øÇÐÀû ¼³°èÀÇ Çõ½ÅÀº ¿Ü°úÀÇ»çÀÇ ´É·Â°ú °á°ú¸¦ Çâ»ó½ÃÄÑ ¼ºÇü¿Ü°ú ºÐ¾ß ¼ö¿ä Áõ°¡¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.
ÃÖÁ¾ ¿ëµµº°·Î´Â ¿Ü·¡ ȯÀÚ ¹× ¿Ü·¡ Áø·á Áõ°¡ Ãß¼¼·Î ÀÎÇØ Ŭ¸®´Ð ºÐ¾ß´Â 2023-2032³â 6.8%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Ŭ¸®´ÐÀº ȯÀÚ¿¡°Ô º¸´Ù Æí¸®ÇÏ°í ºñ¿ë È¿À²ÀûÀÎ ¿É¼ÇÀ» Á¦°øÇϱâ À§ÇØ ´Ù¾çÇÑ ¼Ò±Ô¸ð ¼ö¼úÀ» ÇöÀå¿¡¼ ½ÃÇàÇÏ´Â °æ¿ì°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½Ã¼úÀº Á¤È®Çϰí È¿À²ÀûÀÎ ¼öÇàÀ» À§ÇØ Æ¯¼öÇÑ ÇÚµåÇïµå ±â±â°¡ ÇÊ¿äÇÑ °æ¿ì°¡ ¸¹À¸¸ç, ÀÌ´Â ¼ö¿ä Áõ°¡¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, °¡Ä¡ ±â¹Ý ÀÇ·á ¸ðµ¨·ÎÀÇ ÀüȯÀº Ŭ¸®´ÐÀÌ È¯ÀÚ °á°ú¸¦ °³¼±Çϰí Àüü Ä¡·á ºñ¿ëÀ» Àý°¨ÇÒ ¼ö ÀÖ´Â °íǰÁú Àåºñ¿¡ ÅõÀÚÇϵµ·Ï À¯µµÇÏ¿© Ŭ¸®´Ð ȯ°æ¿¡¼ ¼ö¿ä¸¦ ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù.
Áö¿ªº°·Î º¸¸é, ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÇÚµåÇïµå ¼ö¼ú±â±¸ »ê¾÷Àº 2032³â±îÁö 8.5%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Áß¿äÇÑ ¿øµ¿·Â Áß Çϳª´Â ±Þ¼ºÀåÇÏ´Â ÀÇ·á °ü±¤ »ê¾÷À¸·Î, ¼¼°è ȯÀÚµéÀÌ Àεµ, ű¹, ¸»·¹ÀÌ½Ã¾Æ µîÀÇ ±¹°¡¿¡¼ Àú·ÅÇÑ °¡°Ý¿¡ ¾çÁúÀÇ ¼ö¼ú Ä¡·á¸¦ ¹ÞÀ¸·Á´Â ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀÌ Áö¿ª¿¡¼´Â ºñ¸¸°ú ´ç´¢º´°ú °°Àº »ýȰ½À°üº´ÀÌ Áõ°¡Çϰí ÀÖÀ¸¸ç, ÀÌ´Â ¿Ü°úÀû °³ÀÔ·üÀ» ³ôÀ̰í ÀÖ½À´Ï´Ù. ¶ÇÇÑ Áß±¹, Àεµ¿Í °°Àº ±¹°¡µéÀÇ ¼±Áø ÀÇ·á ±â¼ú µµÀÔ°ú ÀÇ·á ÀÎÇÁ¶ó È®ÃæÀº ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÏ´Â ¸Å¿ì Áß¿äÇÑ ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù.
Global hand-held surgical instruments market will record a 7.4% CAGR between 2023-2032, owing to the rising global geriatric population which is increasing the demand for surgical procedures.
According to estimates from the WHO, one out of six people worldwide will be aged 60 years and over by 2030. As elderly individuals often require medical interventions for various health issues, this increase in population is creating a strong demand for medical equipment such as hand-held surgical instruments. Additionally, the expanding healthcare infrastructure in emerging economies and the growing awareness of healthcare options among the populace are fostering greater access to surgical procedures, further propelling market growth. The COVID-19 pandemic has also underscored the importance of healthcare preparedness, prompting healthcare facilities to invest in state-of-the-art surgical equipment, including hand-held instruments, to address urgent medical needs.
The overall hand-held surgical instruments market is divided based on product, application, end-use, and region.
The dilators product segment will register a 7.7% CAGR through 2032, due to the growing prevalence of minimally invasive surgical techniques. These instruments play a crucial role in dilating blood vessels, tissues, or narrow anatomical structures during various procedures, facilitating access and reducing tissue trauma. As patient preferences shift towards less invasive treatments with quicker recovery times, the need for precise and efficient hand-held dilators has surged.
The plastic surgery application segment will record an 8.3% CAGR over 2023-2032. This is due to the growing emphasis on cosmetic procedures worldwide. Plastic surgeons require specialized instruments for precision and delicate tissue manipulation during surgeries like facelifts, breast augmentation, and rhinoplasties. Moreover, innovations in materials and ergonomic designs are enhancing surgeons' abilities and outcomes, contributing to the heightened demand in the field of plastic surgery.
Based on end-use, the clinics segment will exhibit a 6.8% CAGR between 2023-2032, due to the growing trend towards outpatient and ambulatory care settings. Clinics are increasingly performing a wide range of minor surgical procedures on-site to offer patients more convenient and cost-effective options. These procedures often require specialized hand-held instruments for precise and efficient execution, contributing to the rising demand. Furthermore, the shift towards value-based healthcare models is encouraging clinics to invest in high-quality instruments that can enhance patient outcomes and reduce the overall cost of care, further driving demand in clinic settings.
Regionally, the Asia Pacific hand-held surgical instruments industry will witness an 8.5% CAGR through 2032. One significant driver is the burgeoning medical tourism industry, with patients from around the world seeking affordable and high-quality surgical treatments in countries like India, Thailand, and Malaysia. Additionally, the increasing prevalence of lifestyle-related diseases in this region, such as obesity and diabetes, is boosting surgical intervention rates. The adoption of advanced healthcare technologies and the expansion of healthcare infrastructure in countries like China and India are also pivotal factors driving the market's growth in the Asia Pacific.